MMedication Read More How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q3 Results?October 24, 2025 Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
HHealth care Read More These 3 Beaten-Down Healthcare Stocks Could Have Farther to FallOctober 21, 2025 Moderna could tumble once again, if there’s a lack of positive news in its upcoming earnings release. Novo…
HHealth care Read More Ozempic at Costco? Discount Giant Expands Into $100 Billion Weight-Loss Drug MarketOctober 19, 2025 Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Costco…
MMedication Read More Trump’s $150 Ozempic? Oz cautions it’s not a done deal, but patients and doctors say it could be a gamechangerOctober 19, 2025 Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President…
HHealth care Read More Trump’s $150 Ozempic? Oz cautions it’s not a done deal, but patients and doctors say it could be a gamechangerOctober 18, 2025 Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President…
EEntrepreneurship Read More 50 European corporates backing startups on the path to growth, innovation, and global impactOctober 9, 2025 Across Europe, big companies are becoming strong backers of startup innovation, and corporate venturing is widely used as…
BBusiness Read More Costco to sell Ozempic and Wegovy at discount without insurance – KIRO 7 News SeattleOctober 4, 2025 NATIONAL — Popular weight loss drugs could soon be available at a Costco near you — and possibly…
MMedication Read More How the ‘Ozempic effect’ is reshaping the global economySeptember 12, 2025 Michael Siluk/Alamy The new wave of weight-loss drugs has taken the world by storm. From Novo Nordisk’s Ozempic…
MMedication Read More Wegovy And Zepbound Cost Effective But They Could Break Drug BudgetsSeptember 11, 2025 The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative…
MMedication Read More How a change in FDA guidance might revolutionise MASH drug developmentSeptember 9, 2025 Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) therapy space,…